Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | GABBR2 | O75899 | 5/20 | 0.45 |
| ▸ | GABBR1 | Q9UBS5 | 5/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.45 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.45 |
| ▸ | DRD3 | P35462 | 1/20 | 0.45 |
| ▸ | BLM | P54132 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | THRB | P10828 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.40 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23750200 | 1.00 | HPGD (0.46) | HPGDALDH1A1GABBR2GABBR1LMNA | |
| SCHEMBL23750165 | 0.85 | GABBR2 (0.47) | HPGDALDH1A1GABBR2GABBR1LMNA | |
| SCHEMBL23750201 | 0.85 | GABBR2 (0.47) | HPGDALDH1A1GABBR2GABBR1LMNA | |
| SCHEMBL23750127 | 0.85 | GABBR2 (0.47) | HPGDALDH1A1GABBR2GABBR1LMNA | |
| SCHEMBL23750203 | 0.85 | GABBR2 (0.47) | HPGDALDH1A1GABBR2GABBR1LMNA | |
| SCHEMBL23750252 | 0.84 | GABBR2 (0.46) | GABBR2GABBR1LMNACYP2C9MEN1 | |
| SCHEMBL23750381 | 0.84 | GABBR2 (0.46) | GABBR2GABBR1LMNACYP2C9MEN1 | |
| SCHEMBL23750223 | 0.84 | GABBR2 (0.46) | GABBR2GABBR1LMNACYP2C9MEN1 | |
| SCHEMBL23750382 | 0.84 | GABBR2 (0.46) | GABBR2GABBR1LMNACYP2C9MEN1 | |
| SCHEMBL21609308 | 0.83 | GABBR2 (0.67) | GABBR2GABBR1LMNACYP2C9MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230012121-A1 | COMPOUNDS | SPERO THERAPEUTICS, INC. | 2023-01-12 | — | — | US | disclosed |
| US-20210246169-A1 | COMPOUNDS | SPERO THERAPEUTICS, INC. (US) | 2021-08-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230012121-A1 | COMPOUNDS | MRPS18A, MRPL37, MRPL21 | HPGD 2328/4885ALDH1A1 3966/4885GABBR2 4122/4885 |
| US-20210246169-A1 | COMPOUNDS | MRPS18A, MRPL37, MRPS35 | HPGD 2011/4885ALDH1A1 4011/4885GABBR2 4179/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.